title: Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging.
abstract: OBJECTIVE
  To assess the importance of vascular cognitive impairment and its three subgroups (cognitive impairment, no dementia; vascular dementia; and AD with a vascular component) to the prevalence and burden of cognitive impairment in elderly people.
  
  
  BACKGROUND
  Vascular lesions may produce a spectrum of cognitive changes. Omitting elderly patients whose cognitive impairment falls short of dementia (vascular cognitive impairment, no dementia) may give a falsely low indication of the prevalence and burden of disease. To test this proposition, we compared the rates of adverse outcomes for patients with no cognitive impairment, vascular cognitive impairment (and its subgroups), and probable AD.
  
  
  METHODS
  The Canadian Study of Health and Aging is a prospective cohort study of 10,253 randomly selected community-dwelling and institution-dwelling respondents aged 65 years or older. In the community, all participants (n = 9,008) were screened for cognitive impairment; those who screened positive and a sample of those who screened negative received a clinical assessment (n = 1,659). All patients living in institutions received a clinical assessment (n = 1,255). Participants were reassessed 5 years after the original survey.
  
  
  RESULTS
  Vascular cognitive impairment without dementia was the most prevalent form of vascular cognitive impairment among those aged 65 to 84 years. Rates of institutionalization and mortality for those with vascular cognitive impairment were significantly higher than those of people who had no cognitive impairment, and the mortality rate for patients with vascular cognitive impairment was similar to that of patients with AD.
  
  
  CONCLUSIONS
  Failure to consider vascular cognitive impairment without dementia underestimates the prevalence of impairment and the risk for adverse outcomes associated with vascular cognitive impairment.
authors.affiliation: Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. rockwood@is.dal.ca
authors.forename: K
authors.initials: K
authors.lastname: Rockwood
authors.forename: C
authors.initials: C
authors.lastname: Wentzel
authors.forename: V
authors.initials: V
authors.lastname: Hachinski
authors.forename: D B
authors.initials: DB
authors.lastname: Hogan
authors.forename: C
authors.initials: C
authors.lastname: MacKnight
authors.forename: I
authors.initials: I
authors.lastname: McDowell
mesh_terms: D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002170:Canada / Q000453:epidemiology; D003072:Cognition Disorders / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy; D015140:Dementia, Vascular / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009735:Nursing Homes; D015995:Prevalence; D011446:Prospective Studies; D017678:Sex Distribution; D016896:Treatment Outcome